Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib and PD-1 inhibitors in advanced biliary tract carcinoma
NCT05509478Phase 2Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Aug 2022
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in biliary tract cancer (BTC), sponsored by The First Hospital of Jilin University. Status: unknown.
02
Drugs
lenvatinib
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT05509478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05509478.